Stanford Diffuse Intrinsic Pontine Glioma Research
Thank you for your interest in our recent publication in Nature Medicine. We hope the following announcement will provide you with additional information.
Patients with Diffuse Intrinsic Pontine Glioma, Thalamic Glioma or Spinal Cord Glioma
Thank you again for your interest in our GD2 CAR-T cell research. GD2 CAR-T cell therapy in children with diffuse midline gliomas must be carefully studied, with as many safeguards as possible, to minimize risks to patients.
Our clinical trial opened in June 2020. The primary purpose of this study is to test whether GD2 CAR-T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) or spinal H3K27M-mutant diffuse midline glioma (DMG).
Please carefully review the full list of both inclusion and exclusion criteria for this clinical trial here.
Clinical trials for DIPG and other pediatric cancers
If you would like to explore currently available clinical trials at Stanford for which your child might be eligible, please click here or use the search box found in the upper right hand column of this page . If you want to cast a wider net, ClincialTrials.gov lists many of the clinical trials that are ongoing in the United States and is searchable by location and condition. The International DIPG Registry lists clinical trials that are specific to DIPG.
We understand the desire to have your child’s case reviewed by our experts. Though our staff is not able to comment or provide second opinions on cases via email or phone, we invite you, if you wish, to be seen in person for a second opinion. To make such an appointment, please call the Bass Center for Childhood Cancer and Blood Diseases at (650) 497-8953.
It can be challenging for patients outside of the U.S. to travel to Stanford for treatment or for participation in a clinical trial due to travel logistics and out of pocket costs. If you would still like to consider traveling to Stanford for patient care, please contact Stanford International Medical Services.